Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda [version 1; peer review: 2 approved]

Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda [version 1; peer review: 2 approved]

Introduction: Yellow fever is endemic in specific regions of sub-Saharan Africa and the Americas, with recent epidemics occurring on both continents. The yellow fever vaccine is effective, affordable and safe, providing life-long immunity following a single dose vaccination. However, the vaccine pro...

Full description

Bibliographic Details
Main Authors: Derick Kimathi, Aitana Juan, Philip Bejon, Rebecca F. Grais, George M. Warimwe, YEFE and NIFTY vaccine trials teams
Format: Article
Language:English
Published: Wellcome 2019-11-01
Series:Wellcome Open Research
Online Access:https://wellcomeopenresearch.org/articles/4-182/v1

Similar Items

Similar Items